LOTTE CHEMICAL TITAN HOLDING |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.22 MYR | 0.00% |
|
-4.69% | -9.63% |
| 05-03 | Lotte Chemical Titan Trims Loss in Q1; Shares Drop 3% | MT |
| 05-02 | Lotte Chemical Titan Holding Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 5,478 | 6,296 | 5,466 | 3,234 | 3,075 | 2,779 | - | - |
| Enterprise Value (EV) 1 | 1,562 | 2,138 | 868 | 1,914 | 8,245 | 11,187 | 13,782 | 14,338 |
| P/E ratio | 12.5 x | 42.4 x | 5.16 x | -4.53 x | -3.94 x | -3.61 x | -49.8 x | 35.9 x |
| Yield | 2.9% | 1.18% | 16.3% | - | - | - | - | 1.09% |
| Capitalization / Revenue | 0.65 x | 0.91 x | 0.56 x | 0.32 x | 0.4 x | 0.36 x | 0.34 x | 0.28 x |
| EV / Revenue | 0.19 x | 0.31 x | 0.09 x | 0.19 x | 1.08 x | 1.46 x | 1.68 x | 1.43 x |
| EV / EBITDA | 1.75 x | 2.58 x | 0.53 x | -4.19 x | -23.1 x | -35.7 x | 24.4 x | 15.1 x |
| EV / FCF | 2.88 x | 8.51 x | 1.21 x | -0.41 x | -1.16 x | -2.32 x | -6.9 x | -22.5 x |
| FCF Yield | 34.8% | 11.7% | 82.8% | -245% | -86.5% | -43.1% | -14.5% | -4.44% |
| Price to Book | 0.46 x | 0.53 x | 0.43 x | 0.27 x | 0.27 x | 0.25 x | 0.26 x | 0.27 x |
| Nbr of stocks (in thousands) | 2,272,984 | 2,272,984 | 2,277,557 | 2,277,557 | 2,277,557 | 2,277,557 | - | - |
| Reference price 2 | 2.410 | 2.770 | 2.400 | 1.420 | 1.350 | 1.220 | 1.220 | 1.220 |
| Announcement Date | 1/30/20 | 1/27/21 | 1/27/22 | 1/31/23 | 1/29/24 | - | - | - |
1MYR in Million2MYR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 8,438 | 6,901 | 9,831 | 10,019 | 7,646 | 7,678 | 8,225 | 10,011 |
| EBITDA 1 | 891.2 | 830.3 | 1,647 | -457.1 | -357.1 | -313.1 | 564.2 | 949.2 |
| EBIT 1 | 259.9 | 272 | 1,091 | -1,041 | -868 | -874.5 | 48.7 | -113.4 |
| Operating Margin | 3.08% | 3.94% | 11.1% | -10.39% | -11.35% | -11.39% | 0.59% | -1.13% |
| Earnings before Tax (EBT) 1 | 503.3 | 204 | 1,351 | -985.1 | -999.6 | -1,040 | -78.7 | -260.8 |
| Net income 1 | 442.6 | 154 | 1,058 | -714.6 | -780.3 | -769.1 | -55.7 | 77 |
| Net margin | 5.24% | 2.23% | 10.76% | -7.13% | -10.2% | -10.02% | -0.68% | 0.77% |
| EPS 2 | 0.1935 | 0.0654 | 0.4649 | -0.3138 | -0.3426 | -0.3383 | -0.0245 | 0.0340 |
| Free Cash Flow 1 | 543 | 251.2 | 718.3 | -4,687 | -7,133 | -4,827 | -1,997 | -637.2 |
| FCF margin | 6.43% | 3.64% | 7.31% | -46.78% | -93.29% | -62.87% | -24.28% | -6.37% |
| FCF Conversion (EBITDA) | 60.93% | 30.25% | 43.6% | - | - | - | - | - |
| FCF Conversion (Net income) | 122.69% | 163.07% | 67.9% | - | - | - | - | - |
| Dividend per Share 2 | 0.0700 | 0.0327 | 0.3900 | - | - | - | - | 0.0133 |
| Announcement Date | 1/30/20 | 1/27/21 | 1/27/22 | 1/31/23 | 1/29/24 | - | - | - |
1MYR in Million2MYR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q1 | 2023 Q3 |
|---|---|---|
| Net sales 1 | - | 1,961 |
| EBITDA 1 | - | 98.76 |
| EBIT | - | - |
| Operating Margin | - | - |
| Earnings before Tax (EBT) | - | - |
| Net income | -224.8 | - |
| Net margin | - | - |
| EPS | -0.0987 | - |
| Dividend per Share | - | - |
| Announcement Date | 4/27/23 | 10/26/23 |
1MYR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 5,170 | 8,409 | 11,003 | 11,560 |
| Net Cash position 1 | 3,916 | 4,158 | 4,598 | 1,320 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | -14.48 x | -26.85 x | 19.5 x | 12.18 x |
| Free Cash Flow 1 | 543 | 251 | 718 | -4,687 | -7,133 | -4,827 | -1,997 | -637 |
| ROE (net income / shareholders' equity) | 3.67% | 1.25% | 8.63% | -5.84% | -6.71% | -6.23% | -2.18% | -2.4% |
| ROA (Net income/ Total Assets) | 3.21% | 1.07% | 7.2% | -4.43% | -3.91% | -3.05% | -1.17% | -1.64% |
| Assets 1 | 13,778 | 14,390 | 14,700 | 16,131 | 19,947 | 25,216 | 4,747 | -4,695 |
| Book Value Per Share 2 | 5.260 | 5.190 | 5.590 | 5.170 | 5.050 | 4.810 | 4.690 | 4.560 |
| Cash Flow per Share | 0.4800 | 0.4700 | 0.5100 | - | - | - | - | - |
| Capex 1 | 543 | 826 | 449 | 4,409 | 6,509 | 4,473 | 1,968 | 275 |
| Capex / Sales | 6.44% | 11.96% | 4.57% | 44.01% | 85.13% | 58.26% | 23.93% | 2.75% |
| Announcement Date | 1/30/20 | 1/27/21 | 1/27/22 | 1/31/23 | 1/29/24 | - | - | - |
1MYR in Million2MYR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
1.22
MYR
Average target price
1.072
MYR
Spread / Average Target
-12.09%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -9.63% | 589M | |
| -30.76% | 19.04B | |
| -27.40% | 11.27B | |
| +4.02% | 11.08B | |
| +31.10% | 9.08B | |
| -19.10% | 9.07B | |
| -15.20% | 5.27B | |
| -44.30% | 4.21B | |
| -25.13% | 3.54B | |
| +27.03% | 2.72B |
- Stock Market
- Equities
- LCTITAN Stock
- Financials Lotte Chemical Titan Holding
